References
- Klusmann JH, Creutzig U, Zimmermann M, Dworzak M, Jorch N, Langebrake C, et al.. Treatment and prognostic impact of transient leukaemia in neonates with Down syndrome. Blood. 2008; 111: 2991–8.
- Webb D, Roberts I, Vyas P. Haematology of Down syndrome. Arch Dis Child Fetal Neonatal Ed. 2007; 92: F503–7.
- Tunstall-Pedoe O, Roy A, Karadimitris A, de la Fuente J, Fisk NM, Bennett P, et al.. Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations. Blood. 2008; 112: 4507–11.
- Ahmed M, Sternberg A, Hall G, Thomas A, Smith O, O'Marcaigh A, et al.. Natural history of GATA1 mutations in Down syndrome. Blood. 2004; 103: 2480–9.
- Vyas P, Roberts I. Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis. Early Hum Dev. 2006; 82: 767–73.